Evidence map›Paper›PMID 27585295›Full record

ArticleeLife2016

In vivo genetic dissection of tumor growth and the Warburg effect.

Cheng-Wei Wang, Arunima Purkayastha, Kevin T Jones, Shivani K Thaker, Utpal Banerjee

Open access · goldAbstract read
In one paragraph

Article in eLife, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed
4.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

60 citing papers in PubMed, 102 citations in OpenAlex.

  1. bioRxiv : the preprint server for biology · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Nonautonomous Regulation of Tumor Growth.Advances in experimental medicine and biology · 2025
    Review
  10. Review
  11. Article
  12. Metabolic Recoding of NSUN2-Mediated mAdvanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Frontiers in oncology · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Cheng-Wei WangDepartment of Molecular, Cell and Developmental Biology, University of California, Los Angeles, Los Angeles, United States.
Arunima PurkayasthaDepartment of Molecular, Cell and Developmental Biology, University of California, Los Angeles, Los Angeles, United States.
Kevin T JonesDepartment of Molecular, Cell and Developmental Biology, University of California, Los Angeles, Los Angeles, United States.
Shivani K ThakerDepartment of Molecular, Cell and Developmental Biology, University of California, Los Angeles, Los Angeles, United States.
Utpal BanerjeeDepartment of Molecular, Cell and Developmental Biology, University of California, Los Angeles, Los Angeles, United States.ORCID 0000-0001-6247-0284
University of California, Los Angeles · US

Funding

Signaling and Metabolic Control in the Drosophila EyeR01EY008152 · NEI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI BANERJEE, UTPAL · 1990 to 2015
$6.7M
NEI NIH HHS R01 EY008152
6 · The paper itself

Abstract

A well-characterized metabolic landmark for aggressive cancers is the reprogramming from oxidative phosphorylation to aerobic glycolysis, referred to as the Warburg effect. Models mimicking this process are often incomplete due to genetic complexities of tumors and cell lines containing unmapped collaborating mutations. In order to establish a system where individual components of oncogenic signals and metabolic pathways can be readily elucidated, we induced a glycolytic tumor in the Drosophila wing imaginal disc by activating the oncogene PDGF/VEGF-receptor (Pvr). This causes activation of multiple oncogenic pathways including Ras, PI3K/Akt, Raf/ERK, Src and JNK. Together this network of genes stabilizes Hifα (Sima) that in turn, transcriptionally up-regulates many genes encoding glycolytic enzymes. Collectively, this network of genes also causes inhibition of pyruvate dehydrogenase (PDH) activity resulting in diminished ox-phos levels. The high ROS produced during this process functions as a feedback signal to consolidate this metabolic reprogramming.

Indexed as

Gene Expression Regulation, NeoplasticGlycolysisAnimalsDisease Models, AnimalDNA-Binding ProteinsDrosophilaDrosophila ProteinsGene Regulatory NetworksNeoplasmsOxidative PhosphorylationPyruvate Dehydrogenase ComplexDNA-Binding ProteinsDrosophila ProteinsPyruvate Dehydrogenase ComplexSima protein, Drosophilacancercell biologydevelopmental biologyD. melanogasterhypoxia-inducible factorLDHmetabolismPvrstem cellswarburg effect

Identifiers

PMID27585295
PMCPMC5030086
OpenAlexW2510839345

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.